-JSR Lifesciences invested $1.5M toward the preferred series A capital raise, October 2022.

-The dosing of the P1A Healthy Human Volunteer Study with ALT-100 mAb is nearing completion, with no reported SAEs to date. Study to conclude by Q2 2023.Continue reading→

TapRoot Interventions & Solutions, Inc (TapRoot) is partnering with psychiatric and behavioral health provider group Peace of Mind Consultants (POMC) in Arizona to provide Ella® to their patients and business partners. Ella is a digital careplan platform that provides  interventions to prevent, decrease, and de-escalate dementia-related and mental illness-related behavioral symptoms known to occur in  Long Term Care communities. POMC will use Ella to garner key insights from caregiver feedback in order to tailor patient-specific treatment plans and determine appropriate use of medications. The value of the partnership is a provider service model coupled with a caregiver platform to assess, evaluate, and provide outcome measures to improve overall resident care.Continue reading→

ADP provides an experienced and practical approach for guiding life science clients through the R&D tax credit process. Their group of specialized professionals provide the peace of mind that comes with having a highly detailed study outlining qualified research activities and expenses.Continue reading→

For the first time, Research.com has published a list of the top 1,000 female scientists in the world.

Congratulations to Barbara Ainsworth, Carol Barnes, Carolyn Compton, Nancy Eisenberg, and Alexandra Navrotsky for this well earned recognition.Continue reading→

Bob DeLean to Direct Arizona’s Leading Angel Investing Group’s Next StageContinue reading→

How You Can Help Advance Health InnovationContinue reading→

• This historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy and generates elevated and sustained factor IX levels for years after a one-time infusion
• With the approval of HEMGENIX, CSL now offers an even more comprehensive portfolio of treatments for people living with hemophilia B, ushering in a new era of treatment options 

SOURCE

Continue reading→

The 2023 KEYS Research Internship applications opened November 21, 2022.Continue reading→

PHOENIX, Arizona and OSLO, Norway — November 21, 2022 — Scientists at the Phoenix-based Translational Genomics Research Institute (TGen), part of City of Hope, and EXACT Therapeutics AS (“EXACT-Tx”, Euronext Growth: EXTX), a Norwegian clinical stage precision health company, today report that the ultrasound based Acoustic Cluster Therapy (ACT®) significantly enhanced the antitumor efficacy of standard care therapies in a preclinical model for pancreatic cancer.Continue reading→

Tony Caldwell of Snell & Wilmer, Brandy Flores of Pfizer, Renée Galá of Jazz Pharmaceuticals, Shannon Groppenbacher of Johnson & Johnson, and Nathan Trembath of Bristol Myers Squibb, join the Arizona Bioindustry Association leadership team.Continue reading→